Home › Endometrial Cancer › Georgia › Augusta
Endometrial Cancer clinical trials in Augusta, GA
7 studies for Endometrial Cancer are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Augusta University Medical Center, Augusta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- Augusta University, Augusta
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Augusta University Medical Center, Augusta
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- Georgia Cancer Center at Augusta University, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- Augusta University Georgia Cancer Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Georgia Cancer Center, Augusta
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
RecruitingPhase 2
- Augusta University, Augusta
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Blood Cancers5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Cervical Cancer4 studies
- Myasthenia Gravis4 studies
- Non-Hodgkin Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Burkitt Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.